Exact Sciences (EXAS) News Today $56.95 +0.47 (+0.83%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$56.04 -0.92 (-1.61%) As of 05/23/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EXAS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Woodline Partners LP Sells 59,467 Shares of Exact Sciences Co. (NASDAQ:EXAS)Woodline Partners LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 15.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,988 shares of the medical research company's stock afMay 24 at 5:01 AM | marketbeat.comExact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025May 22 at 5:05 PM | businesswire.comSpyglass Capital Management LLC Has $86.50 Million Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Spyglass Capital Management LLC raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,539,436 shares of the medical research company's stMay 21 at 7:38 AM | marketbeat.com18,250 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Triglav Skladi D.O.O.Triglav Skladi D.O.O. acquired a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,250 shares of the medical research company's stoMay 21 at 6:55 AM | marketbeat.comComerica Bank Lowers Position in Exact Sciences Co. (NASDAQ:EXAS)Comerica Bank lessened its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 75.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,803 shares of the medical research company's stock after selling 5,454 shares during the quarter. Comerica Bank's holdinMay 21 at 3:13 AM | marketbeat.comExact Sciences Corporation (EXAS) Slid on Fear of CompetitionMay 20, 2025 | insidermonkey.comTema Etfs LLC Acquires New Position in Exact Sciences Co. (NASDAQ:EXAS)Tema Etfs LLC purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 15,008 shares of the medical research company's stock, valued at approximatelyMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Trims Holdings in Exact Sciences Co. (NASDAQ:EXAS)Rafferty Asset Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 17.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 212,536 shares of the medical reseMay 19, 2025 | marketbeat.comPolar Asset Management Partners Inc. Has $4.61 Million Position in Exact Sciences Co. (NASDAQ:EXAS)Polar Asset Management Partners Inc. raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,997 shares of the medical resMay 18, 2025 | marketbeat.comPolar Capital Holdings Plc Acquires Shares of 245,402 Exact Sciences Co. (NASDAQ:EXAS)Polar Capital Holdings Plc purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 245,402 shares of the medical research company's stock, valued at approMay 18, 2025 | marketbeat.comCetera Investment Advisers Sells 9,312 Shares of Exact Sciences Co. (NASDAQ:EXAS)Cetera Investment Advisers trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 82,637 shares of the medical researcMay 17, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Exact Sciences (EXAS)May 17, 2025 | theglobeandmail.comEXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin ExpansionMay 16, 2025 | finance.yahoo.comAnalysts Set Exact Sciences Co. (NASDAQ:EXAS) PT at $70.90May 16, 2025 | americanbankingnews.comMeridiem Capital Partners LP Takes Position in Exact Sciences Co. (NASDAQ:EXAS)Meridiem Capital Partners LP purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 202,139 shares of the medical research company's stock, valued at approximately $11,35May 15, 2025 | marketbeat.comGotham Asset Management LLC Reduces Position in Exact Sciences Co. (NASDAQ:EXAS)Gotham Asset Management LLC trimmed its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 150,120 shares of the medical research company's stock after selling 12,302 shares durinMay 15, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-two analysts that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, nineteen have issued a buy ratiMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Acquires 70,000 Shares of Exact Sciences Co. (NASDAQ:EXAS)Integral Health Asset Management LLC boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 87.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the medical researchMay 14, 2025 | marketbeat.com2 Brilliant Stocks to Buy With $200 and Hold for 5 YearsMay 14, 2025 | fool.comIron Triangle Partners LP Buys 200,129 Shares of Exact Sciences Co. (NASDAQ:EXAS)Iron Triangle Partners LP grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 50.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of the medical research compaMay 13, 2025 | marketbeat.comExact Sciences Earns 2025 Great Place To Work® Certification™May 12, 2025 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Granahan Investment Management LLCGranahan Investment Management LLC grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 8.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 444,064 shares of the medical research company's stock after acquiring an additional 33,823 sMay 12, 2025 | marketbeat.comEnsign Peak Advisors Inc Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS)Ensign Peak Advisors Inc increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.3% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,288,876 shares of the medical research company's stock after purchasing aMay 12, 2025 | marketbeat.comFrontier Capital Management Co. LLC Cuts Holdings in Exact Sciences Co. (NASDAQ:EXAS)Frontier Capital Management Co. LLC reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 61.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 225,799 shareMay 12, 2025 | marketbeat.comBokf Na Reduces Stake in Exact Sciences Co. (NASDAQ:EXAS)Bokf Na lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 35.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,481 shares of the medical research company's stock after sellingMay 11, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires 17,231 Shares of Exact Sciences Co. (NASDAQ:EXAS)Schonfeld Strategic Advisors LLC increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 384.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,708 shares of the medical research company'sMay 10, 2025 | marketbeat.comBaird Financial Group Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS)Baird Financial Group Inc. raised its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 335,980 shares of the medical research company's stock after purchasing an adMay 9, 2025 | marketbeat.comNorthern Trust Corp Boosts Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Northern Trust Corp boosted its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 30.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,147,271 shares of the medical research compaMay 9, 2025 | marketbeat.comBraidwell LP Has $19.84 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS)Braidwell LP raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 23.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 353,000 shares of the medical research compMay 8, 2025 | marketbeat.comAmeriprise Financial Inc. Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)Ameriprise Financial Inc. reduced its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,208,039 shares of the medical research company's stock after selling 317,395 shares during the pMay 8, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Up 3.6% Following Analyst UpgradeExact Sciences (NASDAQ:EXAS) Shares Up 3.6% After Analyst UpgradeMay 7, 2025 | marketbeat.comBamco Inc. NY Purchases 265,000 Shares of Exact Sciences Co. (NASDAQ:EXAS)Bamco Inc. NY raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 42.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 893,000 shares of the medical research company's stock after acMay 7, 2025 | marketbeat.comCaisse DE Depot ET Placement DU Quebec Buys New Shares in Exact Sciences Co. (NASDAQ:EXAS)Caisse DE Depot ET Placement DU Quebec bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 14,901 shares of the medical reseMay 7, 2025 | marketbeat.comAvidity Partners Management LP Acquires 15,011 Shares of Exact Sciences Co. (NASDAQ:EXAS)Avidity Partners Management LP raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 603,011 shares of the medical research company's stockMay 6, 2025 | marketbeat.comBellevue Group AG Decreases Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Bellevue Group AG reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 52.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 694,056 shares of the medMay 6, 2025 | marketbeat.comAxa S.A. Sells 19,721 Shares of Exact Sciences Co. (NASDAQ:EXAS)Axa S.A. lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 596,221 shares of the medical research company's stock afterMay 6, 2025 | marketbeat.comLeerink Partnrs Boosts Earnings Estimates for Exact SciencesExact Sciences Co. (NASDAQ:EXAS - Free Report) - Leerink Partnrs boosted their Q4 2025 earnings estimates for shares of Exact Sciences in a report issued on Friday, May 2nd. Leerink Partnrs analyst P. Souda now expects that the medical research company will post earnings per share of $0.26 for thMay 6, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Has $24.70 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)ArrowMark Colorado Holdings LLC increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 439,487 shares of theMay 5, 2025 | marketbeat.comAQR Capital Management LLC Purchases 337,727 Shares of Exact Sciences Co. (NASDAQ:EXAS)AQR Capital Management LLC raised its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 132.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 592,385 shares of the medical researMay 5, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Holdings Raised by Lido Advisors LLCLido Advisors LLC increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 351.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,112 shares of the medical research company's stock aMay 5, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 165,809 Shares of Exact Sciences Co. (NASDAQ:EXAS)Dimensional Fund Advisors LP increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 969,185 shares of the medical research company'May 5, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Gap Up Following Analyst UpgradeExact Sciences (NASDAQ:EXAS) Shares Gap Up Following Analyst UpgradeMay 4, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Price Target Raised to $66.00 at Evercore ISIEvercore ISI raised their target price on Exact Sciences from $60.00 to $66.00 and gave the company an "outperform" rating in a research note on Friday.May 4, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Price Target Raised to $72.00 at Robert W. BairdRobert W. Baird lifted their price objective on shares of Exact Sciences from $69.00 to $72.00 and gave the company an "outperform" rating in a report on Friday.May 4, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: CVS Health (CVS), Exact Sciences (EXAS) and Arvinas Holding Company (ARVN)May 4, 2025 | theglobeandmail.comExact Sciences Co. (NASDAQ:EXAS) Stock Position Reduced by PDT Partners LLCPDT Partners LLC trimmed its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 77.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,226 shares of the medical research company's stock after selling 34,584 sharMay 4, 2025 | marketbeat.comStifel Financial Corp Sells 12,202 Shares of Exact Sciences Co. (NASDAQ:EXAS)Stifel Financial Corp reduced its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 15.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,759 shares of the medical research company'sMay 4, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by NewEdge Advisors LLCNewEdge Advisors LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 66.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,989 shares of the medical research company's stock afterMay 4, 2025 | marketbeat.comExact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not CompellingMay 2, 2025 | seekingalpha.comCancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual GuidanceMay 2, 2025 | benzinga.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼1.350.75▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼1011▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Exelixis News Neurocrine Biosciences News BioMarin Pharmaceutical News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXAS Stock Free EXAS Stock Alerts